ReNerve Limited (ASX:RNV)
0.1100
-0.0050 (-4.35%)
At close: Jun 6, 2025, 4:00 PM AEST
ReNerve Company Description
ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.
It develops NervAlign Nerve Cuff, a protective wrap used to protect repaired injured nerves; NervAlign Nerve Graft, a size-based range of off-the-shelf nerve grafts for the repair of damaged nerves; and NervAlign bionic nerve to produce a replacement nerve that contains shaped ionic polymers, which would enable the stimulation of the distal end of a nerve injury.
The company was incorporated in 2016 and is headquartered in Northcote, Australia.
ReNerve Limited
Country | Australia |
Founded | 2016 |
Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
CEO | Julian Chick |
Contact Details
Address: 157 Heidelberg Road Northcote, 3070 Australia | |
Phone | 61 3 9482 3940 |
Website | renerve.com.au |
Stock Details
Ticker Symbol | RNV |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Julian Chick | Chief Executive Officer |
David Lilja | Chief Financial Officer |